Related Experiment Video
Updated: Jul 28, 2026

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
Published on: July 27, 2014
Hepatocyte growth factor in cerebrospinal fluid in neurologic disease
Y Tsuboi1, K Kakimoto, H Akatsu
1Department of Neuroloy, Mayo Clinic, Jacksonville, Fl 32224, USA. tsuboi.yoshio@mayo.edu
Objective:
To investigate hepatocyte growth factor (HGF) concentration in cerebrospinal fluid (CSF) in neurologic disease.
Materials And Methods:
We determined CSF concentration of HGF with human-HGF-specific enzyme-linked immunosorbent assays (ELISA) in 121 patients: Alzheimer's disease (AD) (33), amyotrophic lateral sclerosis (ALS) (10), Parkinson's disease (PD) (5), progressive supranuclear palsy (PSP) (3), spinocerebellar degeneration (7), acute disseminating encephalomyelitis (ADEM) (6), human T-lymphotropic virus-1 (HTLV-1)-associated myelopathy (HAM) (6), multiple sclerosis (MS) (7), aseptic meningitis (AM) (12), and peripheral neuropathy and myopathy as control diseases (32).
Results:
HGF concentrations in CSF were significantly higher with diseases of the central nervous system (CNS) than control diseases and were slightly higher with AD than other neurodegenerative diseases. Values were highest with ADEM but decreased during corticosteroid treatment. We found no relationship between HGF in CSF and CSF cells or protein, immunoglobulin index, or Q albumin.
Conclusion:
It is suggested that high concentrations of HGF in CSF may be partially related to CNS pathology, especially to demyelinating disease.
More Related Videos
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Neurogenesis and Regeneration of Nervous Tissue
Cerebral Edema ll: Pathophysiology
Hepatic Encephalopathy

